MARLBOROUGH, Massachusetts & YOKNEAM ILLIT, Israel—Lifeward Ltd., a medical technology company, announced that Mark Grant has been appointed as the company’s new president and chief executive officer, effective June 2, 2025. Larry Jasinski, Lifeward’s outgoing CEO, will serve as Co-CEO and, as previously announced, will serve in an advisory capacity until the end of June to assist with the transition, and thereafter on an as-needed basis through the end of 2025.
"Mark brings 30 years of combined experience in commercial leadership, channel development and strategic solutions, and is the perfect choice to lead Lifeward in its next stage of growth,” said Joseph Turk, chairman of the Lifeward Board of Directors. “As a leader, Mark has managed teams in multiple geographies and has led critical functions, including Americas field and inside sales, field clinicians, managed markets, sales channels, health economics and reimbursement, sales training and enablement, revenue cycle management, marketing and global customer service.
“I want to welcome Mark on behalf of the entire Lifeward Board; we look forward to working with him to help drive innovations that change the lives of individuals with physical limitations, impairments or disabilities, including spinal cord injuries," Turk continued. "I also want to thank Larry for his unwavering commitment to Lifeward over the years, and for his valued support in facilitating a seamless leadership transition.”
"As CEO, I look forward to helping Lifeward leverage its many strengths to achieve balanced and sustainable growth as we establish a strong foundation for the future and work strategically toward profitability," Grant said. "Furthermore, I look forward to working with our valued partners in the patient advocacy community who share Lifeward’s profound commitment to improving the quality of life of the patients we have the honor of serving.”
From 2004 to 2023, Grant held various leadership roles at Medtronic, a health care technology company, rising to the level of vice president for the Americas. His responsibilities and achievements included directing the development and execution of strategies to deliver annual revenue targets in the highly competitive diabetic homecare market, opening commercial markets by establishing access to new direct-payer constituencies, including the U.S. Department of Veterans Affairs, optimizing revenue cycle operations, identifying and pursuing new business opportunities based on market trends and competitor research and restructuring the business to meet changing operational demands.
“I’m thrilled and honored to be joining the Lifeward team at such an exciting time in its history,” said Grant. “In the last year, the company has taken great strides, including the major milestone of achieving Medicare payment for the ReWalk exoskeleton while building a robust pipeline of ReWalk cases. ReWalk is representative of Lifeward’s robust portfolio of life-changing, breakthrough solutions, which are based on the company’s wealth of technical expertise, R&D capabilities and patented robotics technology.
Prior to joining Lifeward, Grant was president of Americas and chief commercial officer of IMRA Surgical, a provider in ethical surgical training solutions. While there, he provided executive leadership in setting operational and commercial strategies to establish infrastructure for a new category of surgical procedures through material science. He also spearheaded the development of multi-channel sales and marketing efforts to bolster commercialization efforts and played an integral leadership role in raising capital and developing the company's enterprise strategy.
Before joining Medtronic, Grant had roles at Bristol Myers Squibb and FLA Orthopedics. He has a bachelor of science degree in industrial technology from East Carolina University.